Peering into Analyst’s Take on Target Corporation (NYSE:TGT), Seattle Genetics, Inc. (NASDAQ:SGEN)

Peering into Analyst’s Take on Target Corporation (NYSE:TGT), Seattle Genetics, Inc. (NASDAQ:SGEN)

Wall Street sell-side research analysts covering Target Corporation (NYSE:TGT) shares have recently provided various price target projections on where the stock might be going. According to them, the stock is expected to reach $74.785 on a consensus level within the next year, according to Zacks. The most bullish estimate sees the stock reaching $89 while the most conservative estimate stand at $60.

Zacks also gives an average broker rating based on the sell-side recommendations from the analysts who cover Target Corporation. They give the company shares an ABR of 2.55. This is based on the 14 analysts taken into consideration by Zacks.

Earnings Estimates for Target Corporation (NYSE:TGT)

Currently, Wall Street is projecting that the firm will post $0.83 earnings per share. This consensus number is also derived from Zacks. For the most recent period which ended on 2016-07-31, Target Corporation's EPS was reported as $1.23. This created a “surprise factor” 7.89% due to being $0.09 apart from what Wall Street predicted. When actual numbers differ greatly from the consensus expectations, sharp movement in the stock price can often be seen in the hours or days following the report.

Investors will mark their calendars for 2016-11-16, the date when Target Corporation (NYSE:TGT) are expected to release their quarterly results.

Wall Street sell-side research analysts covering Seattle Genetics, Inc. (NASDAQ:SGEN) shares have recently provided various price target projections on where the stock might be going. According to them, the stock is expected to reach $57.4 on a consensus level within the next year, according to Zacks. The most bullish estimate sees the stock reaching $130 while the most conservative estimate stand at $38.

Zacks also gives an average broker rating based on the sell-side recommendations from the analysts who cover Seattle Genetics, Inc.. They give the company shares an ABR of 2.05. This is based on the 10 analysts taken into consideration by Zacks.

Earnings Estimates for Seattle Genetics, Inc. (NASDAQ:SGEN)

Currently, Wall Street is projecting that the firm will post $-0.29 earnings per share. This consensus number is also derived from Zacks. For the most recent period which ended on 2016-06-30, Seattle Genetics, Inc.'s EPS was reported as $-0.23. This created a “surprise factor” 30.3% due to being $0.1 apart from what Wall Street predicted. When actual numbers differ greatly from the consensus expectations, sharp movement in the stock price can often be seen in the hours or days following the report.

Investors will mark their calendars for 2016-11-03, the date when Seattle Genetics, Inc. (NASDAQ:SGEN) are expected to release their quarterly results.

COMMENTS

WORDPRESS: 0